These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37833198)

  • 1. Applications of designer phage encoding recombinant gene payloads.
    Schmitt DS; Siegel SD; Selle K
    Trends Biotechnol; 2024 Mar; 42(3):326-338. PubMed ID: 37833198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Bacteriophages as Versatile Biologics.
    Kilcher S; Loessner MJ
    Trends Microbiol; 2019 Apr; 27(4):355-367. PubMed ID: 30322741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches for bacteriophage genome engineering.
    Mahler M; Costa AR; van Beljouw SPB; Fineran PC; Brouns SJJ
    Trends Biotechnol; 2023 May; 41(5):669-685. PubMed ID: 36117025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically Engineered Phages: a Review of Advances over the Last Decade.
    Pires DP; Cleto S; Sillankorva S; Azeredo J; Lu TK
    Microbiol Mol Biol Rev; 2016 Sep; 80(3):523-43. PubMed ID: 27250768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Biology to Engineer Bacteriophage Genomes.
    Costa AR; Azeredo J; Pires DP
    Methods Mol Biol; 2024; 2734():261-277. PubMed ID: 38066375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporter Phage-Based Detection of Bacterial Pathogens: Design Guidelines and Recent Developments.
    Meile S; Kilcher S; Loessner MJ; Dunne M
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32858938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic engineering and biological containment of bacteriophages.
    Mitsunaka S; Yamazaki K; Pramono AK; Ikeuchi M; Kitao T; Ohara N; Kubori T; Nagai H; Ando H
    Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2206739119. PubMed ID: 36409909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA and Single-Stranded DNA Phages: Unveiling the Promise from the Underexplored World of Viruses.
    Nguyen HM; Watanabe S; Sharmin S; Kawaguchi T; Tan XE; Wannigama DL; Cui L
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Biology to Engineer Bacteriophage Genomes.
    Rita Costa A; Milho C; Azeredo J; Pires DP
    Methods Mol Biol; 2018; 1693():285-300. PubMed ID: 29119447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions.
    Jia HJ; Jia PP; Yin S; Bu LK; Yang G; Pei DS
    Front Microbiol; 2023; 14():1172635. PubMed ID: 37323893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9 Based Bacteriophage Genome Editing.
    Zhang X; Zhang C; Liang C; Li B; Meng F; Ai Y
    Microbiol Spectr; 2022 Aug; 10(4):e0082022. PubMed ID: 35880867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria.
    Kilcher S; Studer P; Muessner C; Klumpp J; Loessner MJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):567-572. PubMed ID: 29298913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic engineering of bacteriophages: Key concepts, strategies, and applications.
    Hussain W; Yang X; Ullah M; Wang H; Aziz A; Xu F; Asif M; Ullah MW; Wang S
    Biotechnol Adv; 2023; 64():108116. PubMed ID: 36773707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional type II-A CRISPR-Cas system from Listeria enables efficient genome editing of large non-integrating bacteriophage.
    Hupfeld M; Trasanidou D; Ramazzini L; Klumpp J; Loessner MJ; Kilcher S
    Nucleic Acids Res; 2018 Jul; 46(13):6920-6933. PubMed ID: 30053228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering therapeutic phages for enhanced antibacterial efficacy.
    Meile S; Du J; Dunne M; Kilcher S; Loessner MJ
    Curr Opin Virol; 2022 Feb; 52():182-191. PubMed ID: 34952266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Engineering and Rebooting of Bacteriophages in L-Form Bacteria.
    Fernbach J; Meile S; Kilcher S; Loessner MJ
    Methods Mol Biol; 2024; 2734():247-259. PubMed ID: 38066374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically modified bacteriophages.
    Sagona AP; Grigonyte AM; MacDonald PR; Jaramillo A
    Integr Biol (Camb); 2016 Apr; 8(4):465-74. PubMed ID: 26906932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.